Rush MD Anderson Cancer Center at Rush Oak Park — Oak Park, Illinois

Rush MD Anderson Cancer Center at Rush Oak Park is a clinical research site located in Oak Park, Illinois, United States 60304.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Rush MD Anderson Cancer Center at Rush Oak Park has participated in 15 clinical trials with 15 currently active.

Therapeutic areas: Breast Cancer, Ovarian Carcinoma, Biochemically Recurrent Prostate Carcinoma.

Sponsors: NRG Oncology, ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Park

Browse all research sites in Illinois · View every site in Oak Park

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush MD Anderson Cancer Center at Rush Oak Park?

Rush MD Anderson Cancer Center at Rush Oak Park has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush MD Anderson Cancer Center at Rush Oak Park conducted?

Rush MD Anderson Cancer Center at Rush Oak Park has 15 clinical trials on record, with 15 currently active. Their work covers Breast Cancer, Ovarian Carcinoma, Biochemically Recurrent Prostate Carcinoma.

Is Rush MD Anderson Cancer Center at Rush Oak Park accredited by Crixeo Clinical Trials?

Rush MD Anderson Cancer Center at Rush Oak Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush MD Anderson Cancer Center at Rush Oak Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.